awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q58803156-928684A1-12CC-49B8-9E18-254B30E927F2
Q58803156-928684A1-12CC-49B8-9E18-254B30E927F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58803156-928684A1-12CC-49B8-9E18-254B30E927F2
Gefitinib provides similar effectiveness and improved safety than erlotinib for east Asian populations with advanced non-small cell lung cancer: a meta-analysis
P2860
Q58803156-928684A1-12CC-49B8-9E18-254B30E927F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58803156-928684A1-12CC-49B8-9E18-254B30E927F2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
95dedd6ad6fedffac0f32170fcf79c7a0ac709ec
P2860
Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations.